At around $2.20 per share, Clover Health (NASDAQ:CLOV) stock remains in Wall Street’s bargain basement. The meme crowd that briefly sent Clover “to the moon” last summer has not returned for an encore.
As the situation for Clover Health may not be as bad as once feared, now may be the time to buy hard-hit former meme favorite CLOV stock.
But if you’re an investor who buys based on fundamentals rather than on Reddit threads, now may be the time to give this aspiring “disruptor” of the Medicare Advantage Plan business a closer look.
Based upon its latest quarterly numbers and guidance, the situation here may not be as dire as it once seemed.
CLOV Stock and Recent Earnings
The post Recent Results Signal Clover Stock Is a Worthy High-Risk Wager appeared first on InvestorPlace.